title: Reply to "On the mechanism and benefit of siRNA-mediated targeting of CD47 in cancer".
authors.affiliation: Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Yuhua
authors.initials: Y
authors.lastname: Wang
authors.forename: Zhenghong
authors.initials: Z
authors.lastname: Xu
authors.forename: Leaf
authors.initials: L
authors.lastname: Huang
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary*; D008545:Melanoma / Q000188:drug therapy*; D008546:Melanoma, Experimental / Q000473:pathology*; D034741:RNA, Small Interfering / Q000008:administration & dosage*
chemical_list: D034741:RNA, Small Interfering